Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (19,678) $ (12,163)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 446 3,011
Depreciation and amortization 542 360
Loss on extinguishment of warrant liability 504
Change in fair value of warrant liability (10,424)
Change in fair value of derivative liability (401)  
Gain on issuance of convertible note (64)  
Loss on extinguishment of debt 2,345
Change in fair value of notes 7,040
Amortization of deferred debt issuance costs 6,800
Amortization of right-of-use assets 1,141 365
Other expenses 467
Loss on disposal of equipment 380 52
Changes in operating assets and liabilities:    
Prepaid and other assets 136 392
Accounts payable 732 367
Accrued expenses (575) (165)
Lease liabilities (1,200) (268)
Net cash used in operating activities (11,809) (8,049)
CASH FLOWS FROM INVESTING ACTIVITIES    
Cash paid for acquisition of Amerigen 7 (645)  
Purchase of equipment (1,084) (278)
Purchase of patents (61)
Net cash used in investing activities (1,729) (339)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from the exercise of warrants 2,062
Proceeds from the issuance of common stock and warrants, net of fees 855
Proceeds from the issuance of common stock / at-the-market offering 3,957 732
Proceeds from the issuance of notes in connection with line of credit 2,350
Offering costs for the issuance of common stock / at-the-market offering (170) (26)
Proceeds from a deposit for Series D preferred stock (shares liability)   1,039
Proceeds from issuance of Series F-1 preferred stock 2,328
Proceeds from issuance of Series F-2 preferred stock 748
Proceeds from issuance of Senior Secured Notes, net of fees paid 1,357
Repayment of notes payable (2,348)
Proceeds from the issuance of common stock in connection with equity line of credit, net of offering costs 4,489
Net cash provided by financing activities 14,773 2,600
Net increase / decrease in cash 1,235 (5,788)
Cash — beginning of period 821 6,130
Cash — end of period 2,056 342
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Issuance of Series E preferred stock in connection with line of credit 4,350
Issuance of common stock in connection with equity line of credit 114
Issuance of Series F preferred stock in connection with exchange of Series D preferred stock 450
Issuance of common stock in connection with conversion of notes 2,681
Issuance of common stock in connection with Senior Secured Notes settlement 1,160
Issuance of common stock warrants in connection with SLOC 223
Conversion of Senior Secured Notes into Series F preferred stock in connection with Exchange Agreements 82  
Commitment to issue shares of common stock in connection with Demand Notes 286
Unpaid equipment included in accounts payable 23 486
Issuance of common stock warrants in connection with consideration payable 86
SUPPLEMENTAL CASH FLOW INFORMATION    
Cash paid for interest $ 9 $ 3